期刊名称：BLOOD PRESSURE MONITORING
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
| Editor-in-Chief: |
William B. White, MD |
| ISSN: |
1359-5237 |
| Online ISSN: |
1473-5725 |
| Frequency: |
6 issues / year |
| Ranking: |
41 of 67 Peripheral Vascular Disease |
| Impact Factor: |
1.804 |
About the Journal
Page Content
Blood Pressure Monitoring is devoted to original research in blood pressure measurement and blood pressure variability. It includes device technology, analytical methodology of blood pressure over time and its variability, clinical trials - including, but not limited to, pharmacology - involving blood pressure monitoring, blood pressure reactivity, patient evaluation, and outcomes and effectiveness research.
This innovative journal contains papers dealing with all aspects of manual, automated, and ambulatory monitoring. Basic and clinical science papers are considered although the emphasis is on clinical medicine.
Instructions to Authors
Blood Pressure Monitoring accepts manuscript submissions through a submission service on another website.
Blood Pressure Monitoring has specific instructions and guidelines for submitting articles. Those instructions and guidelines are readily available on the submission service site. Please read and review them carefully. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected.
Manuscript Submission
Clicking on the submission service links on this page will open our manuscript submission service website in a new browser window.
Submit a manuscript
|
Blood Pressure Monitoring
Online Submission and Review System |
|
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” at www.icmje.org.
The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing (www.publicationethics.org).
September 18, 2007
Beginning immediately, Blood Pressure Monitoring is implementing a new guideline related to papers detailing independent, clinical validations that use the AAMI, BHS, International Protocols. These studies, which we believe are important and should continue to be published in the Journal, must be shortened so that we have space for other categories of papers. Thus, the following are new requirements for Devices and Validation papers:
1. Word count, including title and references must not exceed 1500 words 2. Limit references to 10 3. Limit figures and tables to 2
Thank you for your understanding - it is the result of the increasing success of our Journal.
Sincerely,
William B. White, MD Professor of Medicine Editor-In-Chief
Scope
Blood Pressure Monitoring is devoted to original research in blood pressure measurement and blood pressure variability. It includes device technology, analytic methodology of blood pressure over time and its variability, clinical trials —including, but not limited to, pharmacology — involving blood pressure monitoring, blood pressure reactivity, patient evaluation, and outcomes and effectiveness research.
Points to consider before submission
Please think carefully about the following points and make the appropriate declarations.
Redundant or duplicate publication
We ask you to confirm that your paper has not been published in its current form or a substantially similar form (in print or electronically, including on a web site), that it has not been accepted for publication elsewhere, and that it is not under consideration by another publication. The International Committee of Medical Journal Editors has provided details of what is and what is not duplicate or redundant publication (www.icmje.org). If you are in doubt (particularly in the case of material that you have posted on a web site), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals. In your covering letter to the editors, draw attention to any published work that concerns the same patients or subjects as the present paper.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
In addition, each author must complete and submit the journal’s copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html). The form is readily available on the manuscript submission page www.editorialmanager.com/bpmj and can be completed and submitted electronically. Please note that authors may sign the copyright transfer agreement form electronically. For additional information about electronically signing this form, go to http://links.lww.com/ZUAT/A106.
Permissions to reproduce previously published material
We ask you to send us copies of permission to reproduce material (such as illustrations) from the copyright holder. We cannot send your paper to press without these permissions!
Patient consent forms
The protection of a patient's right to privacy is essential. We ask you to send copies of patient consent forms on which patients or other subjects of your experiments clearly grant permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. A sample patient consent form is available from the Journal’s website if required.
Ethics committee approval
You must state clearly in your submission in the Methods section that you conducted studies on human participants must with the approval of an appropriate named ethics committee. Please also look at the latest version of the Declaration of Helsinki. Similarly, you must confirm that experiments involving animals adhered to ethical standards and must state the care of animal and licensing guidelines under which the study was performed.
Authorship
We ask that all authors sign the submission letter. First, we have (rarely) had problems when someone named as an author was not aware of the submission of a paper and, on occasion, did not support the findings published. All authors must acknowledge that they have read and approved the paper, they have met the criteria for authorship as established by the International Committee of Medical Journal Editors, that they believe that the paper represents honest work, and that they are able to verify the validity of the results reported. In addition to those from the ICJME the International Society for Medical Publication Professionals, ISMPP (www.ismpp.org) have produced some useful guidelines on authorship of studies sponsored by companies: Good Publication Practice (GPP2) (www.ismpp.org).
Open access
LWW’s hybrid open access option is offered to authors whose articles have been accepted for publication. With this choice, articles are made freely available online immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal’s standard peer-review process and will be accepted or rejected based on their own merit.
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. The article processing charge for Blood Pressure Monitoring is $2,000. The article processing charge for authors funded by the Research Councils UK (RCUK) is $2,580. The publication fee is charged on acceptance of the article and should be paid within 30 days by credit card by the author, funding agency or institution. Payment must be received in full for the article to be published open access. Any additional standard publication charges, such as for color images, will also apply.
- Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant LWW a license to publish the article and identify itself as the original publisher.
- Creative Commons license
Articles opting for open access will be freely available to read, download and share from the time of publication. Articles are published under the terms of the Creative Commons License Attribution-NonCommerical No Derivative 3.0 which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-nc-nd/3.0.
- Compliance with NIH, RCUK, Wellcome Trust and other research funding agency accessibility requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. LWW ensures that authors can fully comply with the public access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access option will have their final published article deposited into PubMed Central.
RCUK and Wellcome funded authors can choose to publish their paper as open access with the payment of an article process charge (gold route), or opt for their accepted manuscript to be deposited (green route) into PMC with an embargo.
With both the gold and green open access options, the author will continue to sign the Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to ensure that the author is fully compliant with the requirements. After signature of the CTA, the author will then sign a License to Publish where they will then own the copyright. Those authors who wish to publish their article via the gold route will be able to publish under the terms of the Attribution 3.0 (CCBY) License. To view of a copy of this license visit: http://creativecommons.org/licenses/by/2.0/. Those authors who wish to publish their article via the green route will be able to publish under the rights of the Attribution Non-commercial 3.0 (CCBY NC) license (http://creativecommons.org/licenses/by-nc/2.0/).
It is the responsibility of the author to inform the Editorial Office and/or LWW that they have RCUK funding. LWW will not be held responsible for retroactive deposits to PMC if the author has not completed the proper forms.
FAQ for open access
http://links.lww.com/LWW-ES/A48
Copyright assignment Papers are accepted for publication on the understanding that exclusive copyright in the paper is assigned to the Publisher. Authors are asked to submit a signed copyright assignment form with their paper. They may use material from their paper in other works published by them after seeking formal permission.
Submissions
Authors are strongly encouraged to submit their manuscripts through the web-based tracking system at http://www.editorialmanager.com/bpmj. The site contains instructions and advice on how to use the system. Authors should NOT in addition then post a hard copy submission to the editorial office, unless you are supplying artwork, letters or files that cannot be submitted electronically, or have been instructed to do so by the editorial office. For those authors who have no option but to submit by mail please send one copy of the article, plus an electronic version on disk or CD-ROM to the following address: Submissions, which should include both a printed manuscript and a disk or CD-ROM, should be sent to: William B. White, MD, Editor-in-Chief, Professor of Medicine, Section of Hypertension and Clinical Pharmacology, The School of Medicine of the University of Connecticut Health Centre, 263 Farmington Avenue, Farmington, Connecticut 06030-3940, USA.
Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate page: title page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Margins should be not less than 3 cm. Pages should be numbered consecutively, beginning with the title page, and the page number should be placed in the top right hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.
Authors are invited to list up to four potential reviewers, including their full addresses, telephone and fax numbers, and e-mail addresses.
Presentation of papers
Title page
The title page should carry the full title of the paper and a short title to be used as a ‘running head’ (and which should be so identified). The first name, middle initial and last name of each author should appear. If the work is to be attributed to a department or institution, its full name should be included. Any disclaimers should appear on the title page, as should the name and address of the author responsible for correspondence concerning the manuscript and the name and address of the author to whom requests for reprints should be made. Finally, the title page should include a statement of conflicts of interest and source of funding, and when none state “none declared”.
Abstracts
The second page should carry a structured abstract of no more than 250 words. The abstract should state the Objective(s) of the study or investigation, basic Methods (selection of study subjects or laboratory animals; observational and analytical methods), main Results (giving specific data and their statistical significance, if possible), and the principal Conclusions. It should emphasise new and important aspects of the study or observations. Review articles and case reports should include an unstructured summary of no more than 150 words.
Keywords
The abstract should be followed by a list of 3–10 keywords or short phrases which will assist the cross-indexing of the article and which may be published. When possible, the terms used should be from the Medical Subject Headings list of the National Library of Medicine (http://www.nlm.nih.gov/mesh/meshhome.html).
Text
Full papers of an experimental or observational nature may be divided into sections headed Introduction, Methods (including ethical and statistical information), Results and Discussion (including a conclusion), although reviews may require a different format.
Acknowledgements
Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions.
References
References should be numbered consecutively in the order in which they first appear in the text. They should be assigned Arabic numerals, which should be given in brackets, e.g.[17]. References should include the names of all authors when six or fewer; when seven or more, list only the first six names and add et al. References should also include full title and source information. Journal names should be abbreviated as in MEDLINE (NLM Catalog, http://www.ncbi.nlm.nih.gov/nlmcatalog).
Articles in journals
Standard journal article:
Agarwal R, Peixoto AJ, Santos SFF, Zoccali C. Out-of-office blood pressure monitoring in chronic kidney disease. Blood Press Monit 2009; 14: 2-11.
More than six authors:
Shirasaki O, Terada H, Niwano K, Nakanishi T, Kanai M, Miyawaki Y, et al. The Japan Home-health Apparatus Industrial Association: investigation of home-use electronic sphygmomanometers. Blood Press Mon 2001; 6:303—307.
Books
Book:
World Health Organization. The World Health Report 2002: reducing risks, promoting life. Geneva: Worls Health Organization; 2002.
Chapter in a book:
Gaddam KK, Gonzaga CC, Calhoun DA. Resistant hypertension. In: Handook of Chronic Kidney Disease Management, Daugirdas JT (editor). Philadelphia: Lippincott Williams & Wilkins; 2011.pp.251-259.
Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words ‘in press’ in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
Tables
Each table should be typed on a separate sheet in double spacing. Tables should not be submitted as photographs. Each table should be assigned an Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should not be used. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text. If you use data from another published or unpublished source, obtain permission and acknowledge the source fully.
Illustrations
A) Creating Digital Artwork
- Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42
- Create, Scan and Save your artwork and compare your final figure to the Digital Artwork Guideline Checklist (below).
- Upload each figure to Editorial Manager in conjunction with your manuscript text and tables.
B) Digital Artwork Guideline Checklist
Here are the basics to have in place before submitting your digital artwork:
- Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution PDF files are also acceptable.
- Crop out any white or black space surrounding the image.
- Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.
- Photographs, radiographs and other halftone images must be saved at a resolution of at least 300 dpi.
- Photographs and radiographs with text must be saved as postscript or at a resolution of at least 600 dpi.
- Each figure must be saved and submitted as a separate file. Figures should not be embedded in the manuscript text file.
Remember:
- Cite figures consecutively in your manuscript. References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2).
- Number figures in the figure legend in the order in which they are discussed.
- Upload figures consecutively to the Editorial Manager web site and enter figure numbers consecutively in the Description field when uploading the files.
- If hard copies are submitted they should have a label pasted to the back bearing the figure number, the title of the paper, the author's name and a mark indicating the top of the figure.
- Illustrations should be presented to a width of 82 mm or, when the illustration demands it, to a width of 166 mm.
- Photomicrographs must have internal scale markers.
- If photographs of people are used, their identities must be obscured or the picture must be accompanied by written consent to use the photograph.
- If a figure has been published before, the original source must be acknowledged and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain.
- Figures may be reduced, cropped or deleted at the discretion of the editor.
- Colour illustrations are acceptable but authors will be expected to cover the extra reproduction costs (for current charges, contact the publisher).
Legends for illustrations
Captions should be typed in double spacing, beginning on a separate page. Each one should have an Arabic numeral corresponding to the illustration to which it refers. Internal scales should be explained and staining methods for photomicrographs should be identified.
Units of measurement
Measurements of length, height, weight, and volume should be reported in metric units (metre, kilogram, or litre) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimetres of mercury.
All haematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Offprints
Offprints may be purchased using the appropriate form that will be made available with proofs. Orders should be sent when the proofs are returned; orders received after this time cannot be fulfilled.
Editorial Board
| Editor-in-Chief |
William B. White
Farmington |
|
Associate Editors |
|
Aldo Peixoto
West Haven |
George A. Mansoor
Rahway |
Contributing Editors |
|
Eoin O'Brien
Dublin |
Jan A. Staessen
Leuven |
Statistics Consulting Editor |
|
Stephen J. Walsh
Farmington |
|
Editor Emeritus (1996-2009) |
|
| Thomas Pickering |
|
Editorial Board |
Bruce S. Alpert
Memphis
Norman Campbell
Alberta
Andrew J.S. Coats
London
Joel E. Dimsdale
La Jolla
Robert Fagard
Leuven
Clarence Grim
Milwaukee
Asbjørn Høegholm
Næstved
Stephen Hunyor
St Leonards (Sydney)
Yutaka Imai
Sendai
Gary D. James
Binghamton
Kazuomi Kario
Tochigi
Lawrence Krakoff
Englewood
Yves LaCourcière
Québec
Björn Lemmer
Mannheim
Jean-Michel Mallion
Grenoble
Giuseppe Mancia
Milan
Décio Mion Jr.
São Paulo
Michael B. Murphy
Cork
Martin G. Myers
Toronto |
Per Omvik
Bergen
Paul L. Padfield
Edinburgh
Paolo Palatini
Padova
Gianfranco Parati
Milan
Sante D. Pierdomenico
Chieti
Francesco Portaluppi
Ferrara
L. Michael Prisant
Augusta
Josep Redon
Valencia
Michael Safar
Paris
Joseph E. Schwartz
Stonybrook
Domenic A. Sica
Richmond, Virginia
Sheldon G. Sheps
Rochester
Kazuyuki Shimada
Tochigi
George S. Stergiou
Athens
Gert A. van Montfrans
Amsterdam
Paolo Verdecchia
Perugia
Bernard Waeber
Lausanne
Michael A. Weber
Brooklyn
Karel H. Wesseling
Amsterdam |
|
